Changes in bone and mineral homeostasis after short-term androgen deprivation therapy with or without androgen receptor signalling inhibitor – substudy of a single-centre, double blind, randomised, placebo-controlled phase 2 trial

BACKGROUND: Prostate cancer (PCa) patients treated with androgen deprivation therapy (ADT) have an increased fracture risk. Exploring biomarkers for early bone loss detection is of great interest. METHODS: Pre-planned substudy of the ARNEO-trial (NCT03080116): a double blind, randomised, placebo-con...

Descripción completa

Detalles Bibliográficos
Autores principales: David, Karel, Devos, Gaëtan, Narinx, Nick, Antonio, Leen, Devlies, Wout, Deboel, Ludo, Schollaert, Dieter, Eisenhauer, Anton, Cavalier, Etienne, Vanderschueren, Dirk, Claessens, Frank, Joniau, Steven, Decallonne, Brigitte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570709/
https://www.ncbi.nlm.nih.gov/pubmed/37804569
http://dx.doi.org/10.1016/j.ebiom.2023.104817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570709/
https://www.ncbi.nlm.nih.gov/pubmed/37804569
http://dx.doi.org/10.1016/j.ebiom.2023.104817

Ejemplares similares